Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics 2001. CA Cancer J Clin 51:15–36
Carter HB, Coffey DS (1990) The prostate: an increasing medical problem. Prostate 16:39–48
Rifkin MD, Friedland GW, Shortliffe L (1986) Prostatic evaluation by transrectal endosonography: detection of carcinoma. Radiology 158:85–90
Halpern EJ, Strup SE (2000) Using gray-scale and color and Power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 174:623–627
Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Discussion 74-Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71
Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45:2–12
Eskew LA, Bare RL, McCullough DL (1997) Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157:199–202
Djavan B, Kadesky K, Klopukh B et al (1998) Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens. Eur Urol 33:261–270
Naughton CK, Miller DC, Mager DE et al (2000) A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 164:388–392
Horninger W, Reissigl A, Fink K et al (1998) Results of a prospective randomized study comparing the prostate cancer detection rates in PSA screening volunteers undergoing 10 vs. 14 transrectal ultrasound guided biopsies. J Urol (Suppl)159:180 abstract 690
Nava L, Montorsi F, Consonni P et al (1997) Results of a prospective randomised study comparing 6, 12, and 18 transrectal, ultrasound guided, sextant biopsies in patients with elevated PSA, normal DRE and normal prostatic ultrasound. J Urol (Suppl) 15:59 abstract 226
Halpern EJ, Frauscher F, Strup SE et al (2002) Prostate: high-frequency Doppler US imaging for cancer detection. Radiology 225:71
Goldberg BB, Liu JB, Forsberg F (1994) Ultrasound contrast agents: a review. Ultrasound Med Biol 20:319–333
Frauscher F, Helweg G, Gotwald TF et al (1998) The value of contrast-enhanced color Doppler ultrasonography in the diagnosis of prostate cancer. Radiology 209:417
Bogers HA, Sedelaar JP, Beerlage HP et al (1999) Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54:97–104
Frauscher F, Klauser A, Halpern EJ et al (2001) Detection of prostate cancer using a microbubble ultrasound contrast agent. Lancet 357:1849–1851
Frauscher F, Klauser A, Volgger H et al (2002) Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167:1648–1652
Halpern EJ, Rosenberg M, Gomella LG (2001) Contrast enhanced sonography of the prostate. Radiology 219:219–225
Halpern EJ, McCue PA, Aksnes AK et al (2002) Contrast enhanced sonography of the prostate: correlation with whole mount prostatectomy specimens. Radiology 222:361–366
Halpern EJ, Frauscher F, Rosenberg M, Gomella LG (2002) Directed biopsy during contrast-enhanced sonography of the prostate. AJR Am J Roentgenol 178:915–919
Halpern EJ, Verkh L, Forsberg F et al (2000) Initial experience with contrast-enhanced sonography of the prostate. AJR Am J Roentgenol 174:1575–1580
Louvar E, Littrup PJ, Goldstein A et al (1998) Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer 183:135–140
Goossen TE, de la Rosette JJ, Hulsbergen-van de Kaa CA et al (2003) The value of dynamic contrast enhanced ultrasound imaging in the localization of prostate cancer. Eur Urol 43:124–131
Eckersley RJ, Sedelaar JP, Blomley MJ et al (2002) Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate 51:256–267
Sedelaar JP, Aarnink RG, van Leenders GJ et al (2000) The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol 37:559–568
Frauscher F, Klauser A, Halpern EJ (2002) Advances in ultrasound for the detection of prostate cancer. Ultrasound Q 18:135–142
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Italia
About this paper
Cite this paper
Frauscher, F. (2005). What Role for Contrast-Enhanced Ultrasound in Prostate Cancer Examination?. In: Contrast-Enhanced Ultrasound in Clinical Practice. Springer, Milano. https://doi.org/10.1007/88-470-0357-1_4
Download citation
DOI: https://doi.org/10.1007/88-470-0357-1_4
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0304-0
Online ISBN: 978-88-470-0357-6
eBook Packages: MedicineMedicine (R0)